Composition
- Active ingredients
- ERYTHROMYCIN ETHYLSUCCINATE EQ 200MG BASE/5ML; SULFISOXAZOLE ACETYL EQ 600MG BASE/5ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA062759.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Erythromycin Ethylsuccinate and Sulfisoxazole Acetyl
- Active substance
- erythromycin ethylsuccinate
- Route
- Oral
- Dosage form
- Granule
- Applicant
- Barr
- Status
- Discontinued
- FDA approval
- 20 May 1988
- Application
- ANDA062759-001